HOME >> MEDICINE >> NEWS
University of Kentucky Gill Heart researchers study abdominal aortic aneurysms

As the baby boomer generation races toward Medicare eligibility, a new screening procedure could mean that many men in the United States may soon learn that they have a killer condition they can do little or nothing about.

Anticipating a surge in diagnosed cases of abdominal aortic aneurysm, a condition for which Medicare just approved a one-time free screening for men, University of Kentucky researchers are working with $8.5 million in NIH funding to understand the condition and how it can be treated.

"In collaborative studies with Lisa Cassis, professor and director of the UK Graduate Center for Nutritional Sciences, we serendipitously developed an animal model of abdominal aneurysms that is not used in many laboratories, This model has provided us with way of defining the mechanisms that initiate and propagate this devastating disease," said Alan Daugherty, Director, UK Cardiovascular Research Center.

In the United States there are currently 78.8 million baby boomers people born between 1946 and 1964. More than half of baby boomers will be age 50 or older by next May, and this January will mark the 60th birthdays of the oldest boomers, according to an analysis of U.S. Census data by American Demographics.

Abdominal aneurysm currently ranks as the 10th leading killer in the United States; although scientists suspect that the incidence may be even higher as the disease is only detected upon autopsy, and autopsies are not always performed in the deaths of older people. The condition primarily affects men over age 55, so the Medicare-covered screening will only be for men. Currently, if a screening detects an abdominal aneurysm, patients face an expensive and unsure course of surgical of treatment. The aneurysm must be monitored, and physicians must use their best judgment to decide when and if surgery is warranted. Open surgery is a long term fix for this disease, but is associated with risks and long recovery times. More rece
'"/>

Contact: Allison Elliott
allison.elliott@uky.edu
859-257-1754
University of Kentucky
23-Jun-2006


Page: 1 2 3

Related medicine news :

1. Indiana University Imaging Center receives $6M grant for kidney research
2. University hospitals wins multiple national IT awards for electronic patient data bank
3. RAND presents first Victor Fuchs Research Award to economists at Carnegie Mellon University
4. University research wins royal accolade
5. New Orleans levee report finished by panel including University of Texas at Austin engineer
6. Boston University School of Medicine faculty member receives honorary degree from alma mater
7. NY-Presbyterian Hospital/Columbia University Medical Center doctors present at 2007 AUA Meeting
8. Emory University researchers find persistent and severe asthma associated with obesity
9. Mid Sweden University leads development of digital color x-rays
10. $2.6M grant awarded to New York University College of Nursing
11. Baby aspirin better for your health, University of Kentucky study says

Post Your Comments:
(Date:6/19/2013)... The former internist for the St. Louis ... serves as director of prevention and wellness at St. ... personal encounter with a metabolic syndrome diagnosis and a ... , that he credits with sparking the paradigm-shift that ... practice. , “The average medical student gets 30 minutes ...
(Date:6/19/2013)... Recently, SoCal CEO Magazine staff was on hand ... in a series of six workshops where people with and without ... the mosaic tiles in their permanent location under the direction of ... Maxwell. , This mural project began in March of 2013 ... three years ago with the goal of promoting ...
(Date:6/19/2013)... The US Food and Drug Administration (FDA) announced ... breast implant, Mentor Worldwide’s MemoryShape™. , The FDA approved Sientra/Silimed ... FDA announced the approval of the MemoryShape™ implant on June ... in women 22 years old or older and in ... FDA’s approval comes after six years of data from 955 ...
(Date:6/19/2013)... the mantra of neurologists treating stroke victims has been "time ... room quickly to receive a drug that dissolves the stroke-causing ... brain tissue is saved or lost. , But ... of giving the intravenous drug known as a tissue ... ischemic (clot-caused), stroke, the most common type of stroke. ...
(Date:6/19/2013)... fact that the incidence of cancer is many fold ... still have an inadequate understanding on how best to ... patients are occasionally included in clinical trials, those elderly ... elderly patients. Thus, the broader elderly patient population is ... in the Elderly Task Force is now starting a ...
Breaking Medicine News(10 mins):Health News:Plant-based Nutrition is Key to Health Transformation of St. Luke’s Hospital Director of Prevention and Wellness 2Health News:Plant-based Nutrition is Key to Health Transformation of St. Luke’s Hospital Director of Prevention and Wellness 3Health News:Arc Creates Huge Mosaic Mural to Highlight the Need for Greater Respect of People with Disabilities 2Health News:FDA Approved Mentor® MemoryShape™ Breast Implants Now Offered to Patients at Swan Center for Plastic Surgery 2Health News:Timely treatment after stroke is crucial, UCLA researchers report 2Health News:Timely treatment after stroke is crucial, UCLA researchers report 3Health News:EORTC study opens for elderly patients with HER-2 positive metastatic breast cancer 2
(Date:6/19/2013)... June 19, 2013   Life Technologies Corporation ... licensing agreement granting Suzhou Ribo Life Sciences (Ribo) ... therapeutics in China using ... proprietary siRNA molecules in combination with Invivofectamine® Rx ... human diseases with high unmet medical need in ...
(Date:6/19/2013)... 19. Juni 2013 Specialty ... der Entwicklung von SCS microRESIST™, einer ... der Beschichtung mit Parylene gelungen ist. ... biokompatiblem Parylene mit antimikrobiellen Eigenschaften und ... Mikroorganismen auf beschichteten medizinischen Geräten. ...
(Date:6/18/2013)... 18, 2013  Intercept Pharmaceuticals, Inc.  (NASDAQ: ... the development and commercialization of novel bile acid therapeutics ... of an underwritten public offering of 1,730,000 shares of ... $33.01 per share.  In addition, Intercept has granted the ... additional 259,500 shares of common stock. All ...
Breaking Medicine Technology:Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 2Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 3Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 4Specialty Coating Systems gibt die Einführung einer neuen antimikrobiellen Parylene-Technologie bekannt 2Intercept Pharmaceuticals Announces Pricing of Public Offering of Common Stock 2
Cached News: